YIH
JANX icon

Y-Intercept (HK)’s Janux Therapeutics JANX Stock Holding History

Y-Intercept (HK)’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
196,487
+56,520
+40% +$819K 0.06% 473
2026
Q1 		$1.95M Buy
+139,967
New +$1.92M 0.04% 728
2025
Q4 		– Sell
-9,241
Closed -$226K – 1774
2025
Q3 		$226K Sell
9,241
-11,361
-55% -$277K 0.01% 1450
2025
Q2 		$476K Buy
20,602
+2,769
+16% +$73K 0.01% 1222
2025
Q1 		$481K Buy
+17,833
New +$672K 0.03% 712
2024
Q4 		– Sell
-6,971
Closed -$317K – 1424
2024
Q3 		$317K Buy
+6,971
New +$303K 0.02% 995

Other funds holding JANX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM